Short Summary
Perfect Corp. and Zugara, Inc. settled their IPR dispute over patent 10,482,517. The Board granted a joint motion to terminate the proceeding and kept the settlement agreement confidential.
Detailed Summary
In IPR2025-01144 concerning U.S. Patent No. 10,482,517, Perfect Corporation (petitioner) and Zugara, Inc. (patent owner) reached a settlement. Both parties filed a joint motion to terminate the inter partes review and a request to treat the settlement agreement as business‑confidential information. The Patent Trial and Appeal Board, before Administrative Patent Judge Kalyan K. Deshpande, granted the motion and the confidentiality request, thereby terminating the proceeding without a final written decision.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Perfect Corporation vs Zugara, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsNetwork-1 Technologies, Inc.
Samsung has filed an IPR petition seeking cancellation of all 20 claims of Network‑1’s U.S. Patent 11,606,204, alleging obviousness over a suite of prior‑art references covering mobile authentication and key‑exchange techniques.
Samsung Electronics Co., Ltd. et al.vsHeadwater Research LLC
Samsung and Headwater Research have settled their dispute over U.S. Patent 8,588,110 and jointly moved to terminate the inter partes review. The Board is asked to dismiss the proceeding under the statutory termination provisions.
OnePlus Technology (Shenzhen) Co., Ltd. et al.vsPantech Corporation
Petitioner OnePlus has filed a Director Review request in IPR2025-00783, asking the PTAB to reconsider the institution decision; the Patent Owner may respond within five business days.
Imperative Care, Inc.vsInari Medical, Inc. et al.
Imperative Care has filed an IPR petition challenging Inari Medical’s U.S. Patent 12,156,669 covering an endovascular clot‑removal system. The petition asserts anticipation and obviousness over multiple prior‑art references, including Garrison, Goff, Brady, Pons, Schaffer, and Hartley. The Board must decide whether to institute the review.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The PTAB initiated a sua sponte Director Review of an IPR involving Sinclair Pharma and others versus Hydrafacial, staying the proceeding after the ITC affirmed the claims’ validity and commercial success.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.